Missed the AD/PD 2022 meeting last month?
Reach out if you would like to catch up with the Cellectricon team to learn more about our services for neurodegenerative disease drug discovery and to receive a copy of our latest poster.
The poster covers the validation of an in vitro alpha-synuclein aggregation assay suitable for target discovery and validation in PD research.
https://www.linkedin.com/feed/update